Healthcare provider profile · identity verified

Amanda Michelle Olson, MD

Family Practice · NASHVILLE, TN · NPI 1902192008

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	457	143
Levothyroxine Sodium	Levothyroxine Sodium	398	113
Losartan Potassium	Losartan Potassium	266	75
Lisinopril	Lisinopril	255	77
Amlodipine Besylate	Amlodipine Besylate	254	73
Sertraline Hcl	Sertraline Hcl	246	70
Omeprazole	Omeprazole	220	65
Hydrochlorothiazide	Hydrochlorothiazide	213	64
Metformin Hcl	Metformin Hcl	174	49
Gabapentin	Gabapentin	166	50
Metoprolol Succinate	Metoprolol Succinate	162	45
Simvastatin	Simvastatin	159	46
Rosuvastatin Calcium	Rosuvastatin Calcium	158	51
Trazodone Hcl	Trazodone Hcl	121	39
Pantoprazole Sodium	Pantoprazole Sodium	117	37
Escitalopram Oxalate	Escitalopram Oxalate	111	34
Bupropion Xl	Bupropion Hcl	108	33
Fluticasone Propionate	Fluticasone Propionate	104	38
Pravastatin Sodium	Pravastatin Sodium	104	27
Montelukast Sodium	Montelukast Sodium	100	26
Alprazolam	Alprazolam	95	26
Amitriptyline Hcl	Amitriptyline Hcl	95	26
Tamsulosin Hcl	Tamsulosin Hcl	93	28
Synthroid	Levothyroxine Sodium	87	23
Zolpidem Tartrate	Zolpidem Tartrate	87	24
Allopurinol	Allopurinol	77	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	74	23
Meloxicam	Meloxicam	73	29
Duloxetine Hcl	Duloxetine Hcl	69	24
Fluoxetine Hcl	Fluoxetine Hcl	67	19
Alendronate Sodium	Alendronate Sodium	61	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	58	20
Citalopram Hbr	Citalopram Hydrobromide	54	15
Lovastatin	Lovastatin	54	17
Potassium Chloride	Potassium Chloride	53	16
Metformin Hcl Er	Metformin Hcl	51	17
Tramadol Hcl	Tramadol Hcl	47	14
Carvedilol	Carvedilol	46	15
Furosemide	Furosemide	46	20
Metoprolol Tartrate	Metoprolol Tartrate	45	15
Jardiance	Empagliflozin	43	11
Atenolol	Atenolol	41	11
Ezetimibe	Ezetimibe	41	13
Lorazepam	Lorazepam	41	suppressed
Benazepril Hcl	Benazepril Hcl	39	12
Ozempic	Semaglutide	39	suppressed
Trulicity	Dulaglutide	39	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	39	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	36	24
Ipratropium Bromide	Ipratropium Bromide	35	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	suppressed
Buspirone Hcl	Buspirone Hcl	33	12
Estradiol	Estradiol	33	13
Glipizide	Glipizide	32	12
Nifedipine Er	Nifedipine	32	suppressed
Diclofenac Sodium	Diclofenac Sodium	31	11
Sumatriptan Succinate	Sumatriptan Succinate	31	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	29	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	29	suppressed
Irbesartan	Irbesartan	28	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Mounjaro	Tirzepatide	27	suppressed
Valsartan	Valsartan	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	11
Celecoxib	Celecoxib	25	suppressed
Diazepam	Diazepam	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Spironolactone	Spironolactone	25	suppressed
Warfarin Sodium	Warfarin Sodium	25	suppressed
Azelastine Hcl	Azelastine Hcl	24	suppressed
Clonazepam	Clonazepam	24	suppressed
Clopidogrel	Clopidogrel Bisulfate	24	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	24	suppressed
Prednisone	Prednisone	24	21
Propranolol Hcl	Propranolol Hcl	24	suppressed
Acyclovir	Acyclovir	23	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	23	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Eliquis	Apixaban	22	suppressed
Glimepiride	Glimepiride	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	suppressed
Naproxen	Naproxen	21	suppressed
Nystatin	Nystatin	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	12
Gemfibrozil	Gemfibrozil	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Glipizide Er	Glipizide	17	suppressed
Ondansetron Odt	Ondansetron	17	13
Ramipril	Ramipril	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Finasteride	Finasteride	16	suppressed
Famotidine	Famotidine	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Baclofen	Baclofen	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Tradjenta	Linagliptin	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	13	suppressed
Temazepam	Temazepam	13	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Exemestane	Exemestane	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	11
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	11
Premarin	Estrogens, Conjugated	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error